Piper Sandler raises MetLife [MET]’s rating to Overweight and price target to $52
Piper Sandler took its MetLife [MET] rating to the equivalent of Overweight from Neutral, and the price target to $52 from $45, in a research note dated 2021-01-06. That figure represents around a 11.47% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with Goldman’s analysts assigning the […]
Barclays raises Barrick Gold [GOLD]’s rating to Overweight
Barclays took its Barrick Gold [GOLD] rating to the equivalent of Overweight from Equal Weight, in a research note dated 2021-01-06. Other analysts also revised their coverage, with Canaccord Genuity’s analysts upgrading the shares from “a Hold” rating to “a Buy” rating in a research note to investors issued in mid August. Meanwhile, Barclays had […]
Wells Fargo lowers American Electric Power [AEP] rating to Equal-Weight and sets price target at $88
Wells Fargo took its American Electric Power [AEP] rating to the equivalent of Equal-Weight from Overweight, and the price target to $88 from $101, in a research note dated 2021-01-06. That figure represents around a 8.07% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with Guggenheim’s analysts upgrading […]
HC Wainwright & Co. reiterates BioXcel Therapeutics [BTAI] at Buy and assigns price target at $185
HC Wainwright & Co. maintained its BioXcel Therapeutics [BTAI] rating to the equivalent of Buy but changed the price target to $185 from $175, in a research note dated 2021-01-06. That figure represents around a 287.52% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with Jefferies’s analysts […]
Credit Suisse raises Arista Networks [ANET]’s rating to Outperform and price target to $351
Credit Suisse took its Arista Networks [ANET] rating to the equivalent of Outperform from Neutral, and the price target to $351, in a research note dated 2021-01-06. That figure represents around a 22.62% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with Evercore ISI’s analysts upgrading the shares […]
Ardelyx [ARDX] Initiated At Overweight by Cantor Fitzgerald
Cantor Fitzgerald launched its Ardelyx [ARDX] rating to the equivalent of Overweight and assigned the price target of $14.0, in a research note dated 2021-01-06. That figure represents around a 120.47% premium from where the company’s shares closed on Tuesday. Meanwhile, Citigroup had launched its coverage on ARDX with “Buy”, in a research note produced […]
Alteryx [AYX] Initiated At Buy by Rosenblatt
Rosenblatt launched its Alteryx [AYX] rating to the equivalent of Buy and assigned the price target of $150.0, in a research note dated 2021-01-06. That figure represents around a 32.93% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with Loop Capital’s analysts assigning the shares to “a […]
Stifel initiates Beam Therapeutics [BEAM] at Hold rating with $84 price target
Stifel launched its Beam Therapeutics [BEAM] rating to the equivalent of Hold and assigned the price target of $84, in a research note dated 2021-01-06. That figure represents around a -0.08% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with Wedbush’s analysts assigning the shares to “an […]
Piper Sandler lowers Beyond Meat [BYND] rating to Neutral and sets price target at $125
Piper Sandler took its Beyond Meat [BYND] rating to the equivalent of Neutral from Overweight, and the price target to $125 from $144, in a research note dated 2021-01-06. That figure represents around a -0.85% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with Piper Sandler’s analysts upgrading […]
Regenxbio [RGNX] Unchanged to Market Perform at SVB Leerink
SVB Leerink maintained its Regenxbio [RGNX] rating to the equivalent of Market Perform but changed the price target to $37 from $34, in a research note dated 2021-01-06. That figure represents around a -17.61% premium from where the company’s shares closed on Tuesday. In addition, RBC Capital Mkts launched coverage on May 13, 2020. The […]
